Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • Research Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • NET National Action Plan
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Bequests
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • Research Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • NET National Action Plan
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Bequests
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » Research » UF Attends 14th Annual ENETs Conference

UF Attends 14th Annual ENETs Conference

  • April 1, 2017
14th Annual ENETs Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease

Over 1500 delegates from around Europe and the world attended this year's annual ENETs conference in Barcelona Spain, to hear about the latest research, treatment options and guidelines in the ongoing care of NET cancer patients.

The conference this year was attended by CEO Simone Leyden, Chair Dr John Leyden and Treasurer Paul Stephenson (as a patient representative), and some of the highlights included the full day ENETs Postgraduate course at the start of the meeting. Topics included: 

– Pathology overview & new advances to aid therapy

– Chromogranin A is dead – Long live the new biomarkers! 

– Lively debate on the role of Interferon in NETs

– Overview of medical management of Pancreatic NETs and ENETs guidelines

Among the robust topics on Thursday 9th March, our friend and Research Advisory Panel member Prof Kjell Oberg was awarded the lifetime achievement award. We could not think of a more deserving person, who has dedicated most of his career to the treatment of NETs. His achievements are many, Prof Öberg was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) 1995-2000 and was past chairman of the Nordic Neuroendocrine Tumour Group. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogues and developed assays for tumor markers such as Chromogranin A and radiological procedures including specialized PET scans. In 1988 he was the first to describe a genetic deletion in multiple endocrine neoplasia Type 1 (MEN1). Prof Oberg is a humble, intelligent and compassionate clinician and researcher and we are grateful to his many years of service and look forward to continuing to work with him.

View post on imgur.com

This year, for the first time INCA (International Neuroendocrine Cancer Alliance) and ENETs held a joint symposium,

Unmet Needs in NET Care and Research: Priorities for Actions. Over the previous months, data was collected from three online surveys (patient leader, patient and family, healthcare professionals) with over 400 respondents in total from 25 countries. Interviews of 40 to 90 minutes were also conducted with 8 medical leaders and 6 patient leaders to provide information for the Whitepaper. Included also were representatives from  key international medical societies ENETS, NANETS (North American Neuroendocrine Tumor Society) and CommNETS (Commonwealth Neuroendocrine Tumor Society) who kindly contributed their time and expertise. Special thanks to Prof Rod Hicks for sitting on the panel at this joint session.

The results of the survey and whitepaper from the patient perspective were presented to close to 200 people by UF's Simone Leyden, with Prof Bertram Wiedenmann of Germany (UF Research Advisory Panel member) presenting on the unmet needs from the physcians' perspective. Some of the key insights can be seen in the below slide.

 
 

One of the most debated insights was the dissemination and relevance of information on NETs and treatments to patients at diagnosis and throughout the journey. This is one of the areas that it was agreed to collaborate to improve, looking at best practice from other cancer groups and creating our own. Research priorities are also an area that patients and physicians need to address to meet expectations on both sides. Special thanks to the expert panel including UF board member Prof Rod Hicks.

We look forward to continuing to contribute to the whitepaper that will be released in the European Spring of 2017. We also would like to thank the NET Research Foundation for their grant to conduct these activities as well as the current ENETs Chairman, Prof Massimo Falconi for his incredible support of the symposium and the ENETs organising committee.

At the end of the conference INCA held their annual patient summit, continuing the theme with experts on collaboration in research. We heard from an expert panel with representatives; Prof Dermot O'Toole (ENETs), Dr David Metz (NANETs), Georg Fisher (NANETs) and Eva Segalov (COMMNETs) about the opportunities and barriers to patient involvement. Special thanks to Prof Eva Segalov for making herself available for the panel.

The 20 member patient groups each had the opportunity to present key activities from the last year and we also workshopped projects that we will be working on over the next year.  Good news is that the "Let's Talk About NETs" campaign was a great success across the globe and we look forward to making it bigger and better in 2017.

To see research highlights of the meeting as reported by Dr John Leyden see below:

https://neuroendocrine.org.au/wp-content/uploads/2020/03/Updates-from-ENETS-2017.pdf 

For the full program of the 14th annual ENETs conference please click below and to see the webcasts of the meeting click here

https://neuroendocrine.org.au/wp-content/uploads/2020/03/14th_Annual_ENETS_Program_2017.pdf

 

 

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

5HIAA Urine Collection Instructions for Patients

June 23, 2022

Donor Report 2021/2022

June 21, 2022

Cancer Nurses Society of Australia 24th Annual Congress

June 18, 2022

The Future of Precision Oncology in Nuclear Medicine – Report

June 16, 2022
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousBreakthrough research into PNET genome sequencing
NextRecruitment onto NABNEC clinical trial openNext

Related Posts

5HIAA Urine Collection Instructions for Patients

Your doctor may order you to do a 5HIAA 24 hour urine test. Please click below to see the downloadable instruction sheet. Previously there were

Donor Report 2021/2022

It is with heartfelt gratitude that we thank our kind donors who enable us to continue to do what we do. We encourage you to

Cancer Nurses Society of Australia 24th Annual Congress

The 24th Cancer Nurses Society of Australia’s  (CNSA) Annual Congress took place at Brisbane Convention Centre Thursday 16 June to Saturday 18 June 2022. The

The Future of Precision Oncology in Nuclear Medicine – Report

Theranostics refers to a combined therapy and diagnostics approach to patient treatment. It involves the use of a diagnostic drug to first identify and label

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • Research Advisory Panel
  • Governance & Policies
Menu
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • Research Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
Menu
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
Menu
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
Menu
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative